EE105 Cost-Effectiveness of Recombinant Factor IX Fc Prophylaxis and Recombinant Factor IX On-Demand Treatment in Patients With Haemophilia B Without Inhibitors
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.357
https://www.valueinhealthjournal.com/article/S1098-3015(22)02561-X/fulltext
Section Title :
Section Order :
12162
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02561-X&doi=10.1016/j.jval.2022.09.357